Virilism – A Comprehensive Medical Guide

Overview

Virilism (also spelled virilism) refers to the development of male secondary sexual characteristics in individuals assigned female at birth (AFAB) or in women. The term is most often used when these changes result from excess androgen exposure, whether from an endocrine disorder, medication, or tumor. Virilism differs from hirsutism, which describes excessive hair growth without the broader spectrum of masculinizing changes.

While virilism can affect anyone with an underlying hormonal imbalance, the majority of reported cases involve adult women ages 20‑50. In the United States, hyperandrogenic conditions (including polycystic ovary syndrome, adrenal tumors, and androgen‑secreting ovarian tumors) affect roughly 5‑10 % of women of reproductive age, but only a small fraction develop full‑blown virilism (CDC, 2022).

Symptoms

Virilism presents as a cluster of signs that together suggest significant androgen excess. The severity depends on the level and duration of exposure.

Cutaneous (Skin) Changes

• Deepening of voice: Vocal cords thicken, leading to a lower pitch that is often irreversible.
• Increased facial and body hair (hirsutism): Coarse, pigmented hair appears on the upper lip, chin, chest, abdomen, and back.
• Acne and oily skin: Sebaceous gland stimulation can cause severe, cystic acne, especially on the forehead, chin, and back.
• Male‑pattern baldness (androgenic alopecia): Thinning of scalp hair in a pattern typical of men.

Reproductive and Sexual Changes

• Clitoral enlargement (clitoromegaly): The clitoris may become visibly enlarged.
• Menstrual irregularities: Oligomenorrhea, amenorrhea, or heavy bleeding.
• Decreased breast size: Reduced glandular tissue and loss of fat.
• Reduced libido or, conversely, increased sexual desire.

Musculoskeletal & Metabolic Effects

• Increased muscle mass and strength: Particularly in the upper body.
• Redistribution of body fat: More abdominal (android) fat and less in hips and thighs.
• Weight gain or, less commonly, weight loss.

Psychological Symptoms

• Mood swings, irritability, or depression.
• Body‑image distress due to rapid physical changes.

Causes and Risk Factors

Virilism results from an excess of circulating androgens (testosterone, dihydrotestosterone, dehydroepiandrosterone sulfate – DHEA‑S). Common etiologies fall into three categories: endocrine disorders, tumors, and exogenous sources.

Endocrine Disorders

• Polycystic Ovary Syndrome (PCOS): The most frequent cause of hyperandrogenism; 70‑80 % of women with PCOS have elevated testosterone, but only 5‑10 % develop virilism (NIH, 2023).
• Congenital Adrenal Hyperplasia (CAH): Enzyme deficiencies (most commonly 21‑hydroxylase) lead to excess adrenal androgen production. Classic CAH presents in infancy; non‑classic forms can emerge in adulthood.
• Adrenal hyperplasia or adenoma: Functional adrenal tumors secrete testosterone or DHEA‑S.

Neoplasms

• Androgen‑secreting ovarian tumors: Sertoli‑Leydig cell tumors and arrhenoblastomas are rare (≈0.1 % of ovarian neoplasms) but often cause rapid virilization.
• Adrenal cortical carcinoma: Aggressive, often metastatic; virilism may be an early clue.
• Metastatic cancers to the adrenal glands.

Exogenous Sources

• Use of anabolic–androgenic steroids (AAS) for bodybuilding or performance enhancement.
• Unguided hormone therapy (e.g., trans‑masculine hormone regimens taken without medical supervision).
• Medications containing testosterone or DHEA (certain anti‑depressants, antineoplastics).

Risk Factors

• Family history of PCOS, CAH, or adrenal tumors.
• Obesity – adipose tissue converts adrenal androgens to more potent forms.
• Age 20‑40 (most tumors and hormonal fluctuations occur in this window).
• Ethnicity – PCOS prevalence is higher in women of South Asian and Hispanic descent.

Diagnosis

Diagnosing virilism requires confirming androgen excess, identifying the source, and excluding benign mimickers.

Clinical Evaluation

• Detailed history: onset, rate of symptom progression, medication/supplement use, menstrual pattern, family history.
• Physical exam: assessment of hair distribution (Ferriman‑Gallwey score), voice pitch, clitoral size, body mass index, and blood pressure.

Laboratory Tests

Test	Typical Findings in Virilism
Serum total & free testosterone	Elevated; >200 ng/dL strongly suggests an androgen‑secreting tumor (Cleveland Clinic).
DHEA‑S	Markedly high in adrenal sources; >700 µg/dL is highly specific.
Luteinizing hormone (LH) & follicle‑stimulating hormone (FSH)	Often low in PCOS due to negative feedback.
17‑hydroxyprogesterone	Elevated in CAH (>200 ng/dL after ACTH stimulation).
Pregnancy test	Rule out pregnancy, which can alter hormone levels.

Imaging Studies

• Transvaginal pelvic ultrasound: Detects ovarian cysts or masses.
• CT or MRI of the abdomen: Evaluates adrenal glands for hyperplasia, adenoma, or carcinoma.
• PET‑CT (if cancer is suspected): Stages metastatic disease.

Additional Tests

• ACTH stimulation test (to assess adrenal enzyme function).
• Genetic testing for CAH mutations when indicated.

Treatment Options

Treatment is individualized, targeting the underlying cause and mitigating symptoms.

Cause‑Specific Therapies

• PCOS: First‑line oral combined oral contraceptives (COCs) reduce ovarian androgen production; anti‑androgens such as spironolactone (50‑200 mg daily) can improve hirsutism and acne.
• CAH: Glucocorticoid replacement (hydrocortisone 10‑20 mg TID) suppresses excess ACTH and adrenal androgen output.
• Androgen‑secreting ovarian or adrenal tumors: Surgical resection (laparoscopic oophorectomy or adrenalectomy) is definitive. Malignant lesions may require adjuvant chemotherapy or radiotherapy.
• Exogenous androgen exposure: Immediate cessation of the offending agent, followed by monitoring for withdrawal effects.

Symptom‑Targeted Medications

• Anti‑androgens: Spironolactone, flutamide, or bicalutamide block androgen receptors; useful when androgen levels cannot be fully normalized.
• 5α‑Reductase inhibitors: Finasteride (1 mg daily) reduces conversion of testosterone to DHT, helping with scalp hair loss.
• Topical eflornithine cream: Decreases facial hair growth; applied twice daily.
• Acne therapy: Combination of topical retinoids, benzoyl peroxide, and oral doxycycline or isotretinoin for severe cases.

Lifestyle & Supportive Measures

• Weight management (10‑15 % weight loss can lower insulin resistance and androgen levels in PCOS).
• Low‑glycemic diet to improve metabolic profile.
• Regular aerobic exercise (≥150 min/week) to enhance insulin sensitivity.
• Psychological counseling or support groups for body‑image concerns.

Living with Virilism

Managing daily life involves both medical and practical strategies.

Skincare & Hair Management

• Gentle skin cleansers; avoid harsh scrubs that can exacerbate acne.
• Consider professional laser hair removal or electrolysis for long‑term reduction of unwanted hair.
• Use hypoallergenic makeup to cover hyperpigmentation; choose non‑comedogenic products.

Voice Changes

• If voice deepening is recent and distressing, speech‑language therapy can help modulate pitch.
• In permanent cases, voice training with a qualified therapist is recommended.

Fertility Considerations

• Women desiring pregnancy should discuss timing of medication cessation with a reproductive endocrinologist.
• Ovulation induction agents (clomiphene citrate or letrozole) are often effective once androgen levels are controlled.

Emotional Well‑Being

• Join online or local support groups for women with hyperandrogenic disorders.
• Mind‑body techniques—yoga, meditation, CBT—can reduce anxiety and improve coping.

Prevention

True primary prevention is limited because many causes are genetic or tumor‑related, but risk can be mitigated:

• Maintain a healthy weight to lower insulin‑driven androgen production.
• Avoid non‑prescribed anabolic steroids and over‑the‑counter androgenic supplements.
• Use hormonal contraception only under medical supervision; never self‑prescribe testosterone.
• Seek early evaluation for irregular periods, rapid hair growth, or unexplained voice changes.

Complications

If left untreated, virilism can lead to both physical and psychosocial sequelae.

• Infertility: Ongoing anovulation and endometrial dysfunction.
• Metabolic syndrome: Increased risk of type 2 diabetes, hypertension, and dyslipidemia.
• Cardiovascular disease: Chronic androgen excess is associated with atherosclerosis.
• Psychological distress: Depression, anxiety, and reduced quality of life.
• Irreversible changes: Deepened voice and clitoromegaly may not fully regress even after hormonal control.
• Malignancy: Undiagnosed androgen‑secreting adrenal or ovarian cancers can be fatal.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH, WHO, Cleveland Clinic, peer‑reviewed endocrine journals (e.g., *The Journal of Clinical Endocrinology & Metabolism*, 2022‑2024).